Interplay of TRIM2 E3 Ubiquitin Ligase and ALIX/ESCRT Complex: Control of Developmental Plasticity During Early Neurogenesis.
Animals
Body Patterning
/ genetics
Cell Cycle Proteins
/ genetics
Cell Proliferation
/ genetics
Cell Survival
/ genetics
Ectoderm
/ metabolism
Embryo, Nonmammalian
/ metabolism
Endosomal Sorting Complexes Required for Transport
/ metabolism
Gene Expression Regulation, Developmental
HEK293 Cells
Humans
Morpholinos
/ pharmacology
Motor Activity
/ drug effects
Neurogenesis
/ genetics
Neuronal Plasticity
/ genetics
Neurons
/ cytology
Protein Binding
/ drug effects
Tripartite Motif Proteins
/ genetics
Ubiquitin-Protein Ligases
/ genetics
Xenopus
/ embryology
Xenopus Proteins
/ genetics
Alix
Trim2
Xenopus
apoptosis
ataxia
neural development
neural differentiation
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
20 07 2020
20 07 2020
Historique:
received:
10
06
2020
revised:
13
07
2020
accepted:
15
07
2020
entrez:
24
7
2020
pubmed:
24
7
2020
medline:
5
3
2021
Statut:
epublish
Résumé
Tripartite motif 2 (TRIM2) drives neurite outgrowth and polarization, is involved in axon specification, and confers neuroprotective functions during rapid ischemia. The mechanisms controlling neuronal cell fate determination and differentiation are fundamental for neural development. Here, we show that in
Identifiants
pubmed: 32698497
pii: cells9071734
doi: 10.3390/cells9071734
pmc: PMC7409263
pii:
doi:
Substances chimiques
Cell Cycle Proteins
0
Endosomal Sorting Complexes Required for Transport
0
Morpholinos
0
PDCD6IP protein, Xenopus
0
Tripartite Motif Proteins
0
Xenopus Proteins
0
Trim2 protein, Xenopus
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Mol Neurosci. 2012 Feb;46(2):324-35
pubmed: 21720722
Nat Commun. 2020 Apr 22;11(1):1941
pubmed: 32321914
J Vis Exp. 2016 Oct 31;(116):
pubmed: 27842370
J Comp Neurol. 2000 Jul 31;423(3):512-31
pubmed: 10870090
J Cell Sci. 2003 Jul 15;116(Pt 14):2845-55
pubmed: 12771190
J Virol. 2019 Apr 17;93(9):
pubmed: 30760577
J Neurochem. 2001 Jul;78(1):75-87
pubmed: 11432975
Sci Rep. 2017 Mar 21;7:44767
pubmed: 28322231
Dev Biol. 1998 Nov 1;203(1):36-48
pubmed: 9806771
J Cell Biol. 2020 Mar 2;219(3):
pubmed: 32049272
J Biol Chem. 2004 Jan 16;279(3):2046-52
pubmed: 14585841
Cell Death Differ. 1999 Feb;6(2):124-9
pubmed: 10200558
J Biol Chem. 1999 Jan 15;274(3):1533-40
pubmed: 9880530
Neuroscience. 2004;123(4):887-95
pubmed: 14751282
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9
pubmed: 14519844
Methods Cell Biol. 1991;36:685-95
pubmed: 1811161
Mol Cell Neurosci. 2005 May;29(1):74-81
pubmed: 15866048
J Mol Biol. 2000 Feb 4;295(5):1103-12
pubmed: 10653689
PLoS One. 2013 Jun 04;8(6):e64870
pubmed: 23750217
J Biol Chem. 2011 Jun 3;286(22):19331-9
pubmed: 21478148
Bioessays. 2004 Jun;26(6):604-7
pubmed: 15170857
Mol Cell Proteomics. 2015 Jan;14(1):120-35
pubmed: 25363814
Neurobiol Dis. 2020 Jul;140:104845
pubmed: 32205255
Biochim Biophys Acta. 2014 Jan;1843(1):47-60
pubmed: 23747565
J Biol Chem. 2000 Jun 23;275(25):19275-81
pubmed: 10858458
J Neurosci. 2006 Jan 11;26(2):542-9
pubmed: 16407552
Hum Mol Genet. 2013 Aug 1;22(15):2975-83
pubmed: 23562820
Hum Pathol. 2016 Jun;52:110-8
pubmed: 26980041
Cell. 2003 Sep 19;114(6):701-13
pubmed: 14505570
Oncogene. 2002 Oct 3;21(44):6801-8
pubmed: 12360406
Mol Neurodegener. 2017 Apr 11;12(1):29
pubmed: 28399880
J Biol Chem. 2003 Oct 3;278(40):39104-13
pubmed: 12860994
Cell. 2003 Sep 19;114(6):689-99
pubmed: 14505569
Int J Mol Sci. 2019 Jun 02;20(11):
pubmed: 31159502
Dev Biol. 2001 Jan 15;229(2):307-18
pubmed: 11150237
J Neurochem. 2011 Apr;117(1):29-37
pubmed: 20796172
Semin Cell Dev Biol. 2015 Dec;47-48:52-9
pubmed: 26514622
J Biol Chem. 1999 Feb 26;274(9):5522-31
pubmed: 10026166
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):12016-21
pubmed: 18687884